CGAS and HIV infectious disease: On the other hand, in HIV infection, TREX1 activity promotes a decrease in viral DNA below the threshold of immune activation, inhibiting the adequate activation of cGAS-STING and the production of IFN-I, which are essential for the control of viral infections [25].